Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and WalesResearch in context

Summary: Background: UK COVID-19 vaccination policy has evolved to offering COVID-19 booster doses to individuals at increased risk of severe Illness from COVID-19. Building on our analyses of vaccine effectiveness of first, second and initial booster doses, we aimed to identify individuals at incr...

Full description

Bibliographic Details

Published in:	The Lancet Regional Health. Europe
Main Authors:	Stuart Bedston, Fatima Almaghrabi, Lynsey Patterson, Utkarsh Agrawal, Lana Woolford, Sneha N. Anand, Mark Joy, Anna Crawford, Rosalind Goudie, Rachel Byford, Hoda Abbasizanjani, Deb Smith, Lynn Laidlaw, Ashley Akbari, Christopher Sullivan, Declan T. Bradley, Ronan A. Lyons, Simon de Lusignan, F.D. Richard Hobbs, Chris Robertson, Sir Aziz Sheikh, Ting Shi
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Subjects:	COVID-19 Vaccine Hospital admission Vaccine breakthrough Booster dose
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666776223002351